Navigation Links
iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
Date:7/7/2009

chnology.

Because iPS cells are believed to be able to grow indefinitely in culture and to differentiate into many cell types, iPS cells have great potential for disease research, preclinical drug testing and cell-based therapy. iPierian's approach places the patient at the forefront of the drug discovery process, thereby reducing drug development time and increasing the probability of success for drug candidates. iPierian plans to use precise human disease models to find new molecular targets and develop proprietary therapeutic small molecule or biologic drugs for its own pipeline to treat specific diseases.


'/>"/>
SOURCE iZumi Bio, Inc.; Pierian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease
2. iZumi Bio, Inc. Recruits Leading iPS Scientist, John Dimos, to Translate Stem Cell Breakthrough Into Patient Benefits
3. iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer
4. iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development
5. iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. ev3 and FoxHollow Announce Date for Special Meeting of FoxHollow Stockholders to Vote on Proposed Merger
10. IsoTis - Integra Merger
11. New Brunswick Scientific Completes Merger Transaction with Eppendorf
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... MX (PRWEB) September 18, 2014 September ... Mexico City, MX. ASEA is the manufacturer of the ... the skin care product, RENU28. , The Mexico ... Vice President Duvan Botero, and ASEA Field Leader Shawn ... holds a PhD in Atomic/Medical Physics from the University ...
(Date:9/17/2014)... - Oncothyreon Inc. (NASDAQ: ONTY ) today ... of its Common Stock and Series A Convertible Preferred ... Series A Convertible Preferred Stock is non-voting and convertible ... will be prohibited if, as a result, the holder ... of the Common Stock then outstanding. As part of ...
(Date:9/17/2014)... September 17, 2014 A biodegradable ... microorganisms such as bacteria, fungi, and algae into ... methane, biomass, inorganic compounds, carbon dioxide, and humus ... customer base and improved costs, biodegradable polymers are ... viable alternative to conventional polymers. Primary factors that ...
(Date:9/17/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... cost and predictability of non-adherence in type 2 diabetes ... the European Association for the Study of Diabetes (EASD). ... Ph.D., of Analysis Group, Inc. presented data from the ... to characterize the prevalence of non-adherence and serial non-adherence, ...
Breaking Biology Technology:Announcing the ASEA Mexico Grand Opening Tour Beginning September 18th 2Oncothyreon Announces Proposed Public Offerings 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5
... Pioneering medical device company Signostics announced today ... Food and Drug Administration (FDA) for its ... http://www.newscom.com/cgi-bin/prnh/20090519/SF19276 )Signostics has developed a cost-effective device ... affordable for individual health professionals to use ...
... Inc. (TSX:SBS), specializing in the manufacture of high-value ... encouraging data from the Company,s Apo AI(Milano) development ... SemBioSys, plant-derived Apo AI(Milano) has exhibited the appropriate ... plaque volume. , New data from two of ...
... NANJING, China, May 19 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(NYSE: ... of branded generic and,innovative anti-cancer pharmaceuticals in China, announced ... Officer. , Dr. Wang will ... and,innovative research projects. He will also participate in ...
Cached Biology Technology:Signostics Receives FDA Clearance for World's Smallest Ultrasound Product 2SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 2SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 3SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 4Simcere Pharmaceutical Group Appoints Dr. Peng Wang as Chief Scientific Officer 2
(Date:9/17/2014)... an EC-FP5 four-year project, delivering its first release in ... participations in several EC projects, as a part of ... (EU BON), to increase the general awareness of the ... general dissemination of the Fauna Europaea results, the ... novel e-Publishing tools to prepare data papers for all ...
(Date:9/17/2014)... plastic shopping bags and their environmental impact recently scored ... first statewide ban on the bags, and Governor Jerry ... bag industry is not yielding without a fight, according ... , the weekly newsmagazine of the American Chemical Society. ... that the anti-bag campaign logged its first small victory ...
(Date:9/17/2014)... have obtained the first partial genome sequence of an ... at the site of the Montsoriu Castle in Girona, ... closely related to today,s Iberian pig. Researchers also discard ... Iberian pigs. , The study, published in Heredity ... species, and particularly on that of the Iberian breed, ...
Breaking Biology News(10 mins):Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2Iberian pig genome remains unchanged after 5 centuries 2
... press release is available in German . ... at the Max Planck Institute for Developmental Biology in ... to identify neuronal correlates of behaviour by comparing maps ... different behaviour. They compared the pharyngeal nervous systems of ...
... had been in the business of trading wetlands rather than ... current guidelines for wetland restoration. Research from the University of ... over wetland restoration sites result in more environmentally positive outcomes. ... under the current policies if a wetland is scheduled for ...
... in The Journal of General Physiology ... results, indicating that the extracellular accumulation of potassium that ... thought. Muscle excitation involves the influx of sodium ... of ions that cross the muscle membrane with each ...
Cached Biology News:The neurobiological consequence of predating or grazing 2The neurobiological consequence of predating or grazing 3Trading wetlands no longer a deal with the devil 2Trading wetlands no longer a deal with the devil 3Study offers new insights into the mechanics of muscle fatigue 2
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: